<DOC>
	<DOCNO>NCT00372957</DOCNO>
	<brief_summary>To investigate preliminary pharmacokinetics , pharmacodynamics , safety tolerability GW823093 dose 15mg 30mg give daily 7 day Japanese Type 2 diabetes mellitus ( T2DM ) patient .</brief_summary>
	<brief_title>Study Of GW823093 In Japanese Subjects With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Inclusion criterion : T2DM diagnose least 3 month prior Screening fast plasma glucose ( FPG ) level &lt; 280mg/dL Screening visit . Concurrent T2DM therapy : Must diet control OR take 2 oral antidiabetic agent , willing withdraw treatment 2 week prior first dose . Exclusion criterion : Must major illness diabetes</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>pharmacodynamics</keyword>
	<keyword>pharmacokinetics</keyword>
</DOC>